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Introduction {#embj201798791-sec-0001}
============

The subventricular zone (SVZ) of the lateral ventricles is the primary neurogenic niche of the adult mammalian brain harboring neural stem cells (NSC) throughout life. This endogenous source of new neurons holds great potential toward therapy, and major efforts are aimed to understand the mechanisms governing the proliferation and differentiation of NSC and the role of adult neurogenesis in cognitive performance and brain plasticity (Silva‐Vargas *et al*, [2013](#embj201798791-bib-0053){ref-type="ref"}; Lim & Alvarez‐Buylla, [2014](#embj201798791-bib-0034){ref-type="ref"}; Lepousez *et al*, [2015](#embj201798791-bib-0033){ref-type="ref"}; Sailor *et al*, [2017](#embj201798791-bib-0049){ref-type="ref"}).

Specifically, slowly dividing progenitors of embryonic origin (Fuentealba *et al*, [2015](#embj201798791-bib-0019){ref-type="ref"}; Furutachi *et al*, [2015](#embj201798791-bib-0020){ref-type="ref"}) become activated NSC (B1 cells) of the adult SVZ and give rise to intermediate progenitors (C cells) that produce neuroblasts (A cells) migrating through the rostral migratory stream (RMS) and generating interneurons of the olfactory bulb (OB; Doetsch *et al*, [1997](#embj201798791-bib-0016){ref-type="ref"}). As a result, newborn granule and periglomerular cells are continuously added to the OB, contributing to the plasticity of the local circuitry throughout life by modulating the activity of mitral and tufted cells whose output is projected to the olfactory cortex (Hack *et al*, [2005](#embj201798791-bib-0024){ref-type="ref"}; Mizrahi *et al*, [2006](#embj201798791-bib-0038){ref-type="ref"}; Brill *et al*, [2009](#embj201798791-bib-0012){ref-type="ref"}; Ghosh *et al*, [2011](#embj201798791-bib-0022){ref-type="ref"}; Miyamichi *et al*, [2011](#embj201798791-bib-0036){ref-type="ref"}).

Studies attempting to link neurogenesis with olfaction yielded conflicting results pointing to a yet unresolved debate about the role of newborn neurons. For instance, depleting NSC decreased olfactory memory with some (Sakamoto *et al*, [2014](#embj201798791-bib-0050){ref-type="ref"}) or no (Breton‐Provencher *et al*, [2009](#embj201798791-bib-0010){ref-type="ref"}; Lazarini *et al*, [2009](#embj201798791-bib-0032){ref-type="ref"}) effect on odor discrimination or learning. Similarly, impairing the migration or survival of newborn neurons had either no effect (Kim *et al*, [2007](#embj201798791-bib-0026){ref-type="ref"}) or inhibited odor discrimination (Gheusi *et al*, [2000](#embj201798791-bib-0021){ref-type="ref"}; Bath *et al*, [2008](#embj201798791-bib-0007){ref-type="ref"}). Seemingly contradicting these findings, promoting neuronal survival also decreased odor discrimination (Mouret *et al*, [2009](#embj201798791-bib-0040){ref-type="ref"}) or, alternatively, improved learning (Wang *et al*, [2015](#embj201798791-bib-0056){ref-type="ref"}). Moreover, activating newly integrated cells was reported to facilitate learning and memory by some studies (Alonso *et al*, [2012](#embj201798791-bib-0003){ref-type="ref"}; Gschwend *et al*, [2015](#embj201798791-bib-0023){ref-type="ref"}), while, conversely, others showed that enhancing the inhibitory activity of all granule cells in the OB improved odor discrimination time but not learning or memory (Abraham *et al*, [2010](#embj201798791-bib-0002){ref-type="ref"}; Nunes & Kuner, [2015](#embj201798791-bib-0043){ref-type="ref"}).

These inconsistencies are likely due to the very different approaches previously used by which the intrinsic properties of the mature and/or newborn neurons themselves have been manipulated including at the level of their migration, survival, integration, or electrophysiological properties. In fact, studies investigating whether a specific expansion of NSC resulting in an increased number of otherwise physiologically normal, unmanipulated neurons improves brain function are lacking. Addressing this question is fundamental to identify the specific role of adult neurogenesis in olfaction and explore systems to expand NSC, and perhaps also other somatic stem cells, for therapy.

Our and other groups have shown that the cell cycle regulators Cdk4/cyclinD1 (4D) can be used to regulate the expansion not only of NSC (Lange *et al*, [2009](#embj201798791-bib-0029){ref-type="ref"}; Artegiani *et al*, [2011](#embj201798791-bib-0004){ref-type="ref"}; Nonaka‐Kinoshita *et al*, [2013](#embj201798791-bib-0042){ref-type="ref"}) but also human hematopoietic (Mende *et al*, [2015](#embj201798791-bib-0035){ref-type="ref"}) and pancreatic β‐cell (Azzarelli *et al*, [2017](#embj201798791-bib-0005){ref-type="ref"}; Krentz *et al*, [2017](#embj201798791-bib-0027){ref-type="ref"}) precursors. Hence, here we decided to develop a versatile transgenic mouse model to temporarily control 4D in any tissue of choice. We then used this tool to assess the effects of a cell‐intrinsic expansion of adult NSC without a manipulation of their niche and resulting in the increased generation of physiologically normal neurons to study their role in olfactory performance.

Results {#embj201798791-sec-0002}
=======

Temporal control of NSC expansion in the SVZ {#embj201798791-sec-0003}
--------------------------------------------

Our group has shown that a transient 4D overexpression promoted the proliferation of NSC by shortening their cell cycle, specifically G1. Concomitantly, a shortening of G1 promoted a switch of NSC fate from differentiative to proliferative divisions resulting in the subsequent increase in the number of newborn neurons generated during embryonic cortical development and adult hippocampal neurogenesis (Lange *et al*, [2009](#embj201798791-bib-0029){ref-type="ref"}; Artegiani *et al*, [2011](#embj201798791-bib-0004){ref-type="ref"}; Nonaka‐Kinoshita *et al*, [2013](#embj201798791-bib-0042){ref-type="ref"}). Therefore, in order to investigate the effects of increased neurogenesis in odor discrimination, we generated a triple transgenic mouse line by crossing *nestin* ^CreERT2^ (Imayoshi *et al*, [2008](#embj201798791-bib-0025){ref-type="ref"}), *ROSA26* ^rtTA‐flox^ (Belteki *et al*, [2005](#embj201798791-bib-0008){ref-type="ref"}), and *tet* ^4D‐RFP^ (Nonaka‐Kinoshita *et al*, [2013](#embj201798791-bib-0042){ref-type="ref"}) mice (Fig [1](#embj201798791-fig-0001){ref-type="fig"}A). This system was designed to allow the tamoxifen (Tam)‐dependent activation of rtTA specifically in NSC followed by an inducible and reversible 4D expression, together with RFP as reporter, in a doxycycline (Dox), time‐dependent manner. Notably, the *ROSA26* ^rtTA‐flox^/*tet* ^4D‐RFP^ line would also allow 4D to be in principle controlled in any other tissue of choice by simply crossing this line with any appropriate Cre driver mouse.

![Transgenic model and effects of acute 4D overexpression on NSC and progenitors of the SVZ\
Drawings of the *nestin* ^CreERT2^ (Imayoshi *et al*, [2008](#embj201798791-bib-0025){ref-type="ref"}), *ROSA26* ^rtTA‐flox^ (Belteki *et al*, [2005](#embj201798791-bib-0008){ref-type="ref"}), and *tet* ^4D‐RFP^ (Nonaka‐Kinoshita *et al*, [2013](#embj201798791-bib-0042){ref-type="ref"}) alleles of the 4D line.From top to bottom: experimental design of 4D induction, fluorescence pictures of the SVZ of a 4D^+^ mouse and quantification of the proportion of RFP^−^ (black) and RFP^+^ (red) progenitors among B1, C, and A cells identified with markers as indicated.From top to bottom: experimental design, fluorescence pictures of the SVZ of a 4D^−^ (left) and 4D^+^ (right and insets magnified) mice, and quantification of the proportion of BrdU^+^ among B1, C, and A cells (identified as in B). Note that in 4D^+^ mice quantification was restricted to the RFP^+^ subpopulation (red bars).Quantification of the absolute number of B1, C, and A cells (identified as in B) in the SVZ of 4D^−^ (white) and 4D^+^ (black) mice regardless of RFP expression (RFP^+/−^).Data information: (B--D) Mean ± SEM; \**P *\<* *0.05 and \*\**P *\<* *0.01 calculated by unpaired Student\'s *t*‐test; *N* = 3 mice, *n* \> 423 cells for each quantification. Scale bar = 50 μm (B and C) or 20 μm (inset in C).](EMBJ-38-e98791-g002){#embj201798791-fig-0001}

Triple homozygous, adult *nestin* ^CreERT2+/+^/*ROSA26* ^rtTA‐flox+/+^/*tet* ^4D‐RFP+/+^ mice (referred to as 4D^+^; see [Materials and Methods](#embj201798791-sec-0008){ref-type="sec"} and [Appendix](#embj201798791-sup-0001){ref-type="supplementary-material"}) for the strategy used to obtain this line) were administered Tam for 3 days followed by 4 days of clearance and the subsequent start of Dox administration (defined to as day 0; Fig [1](#embj201798791-fig-0001){ref-type="fig"}B). After 4 days of Dox, both RFP mRNA and endogenous fluorescence were detected along the SVZ and RMS that, as expected, still did not reach the OB (Fig [EV1](#embj201798791-fig-0001ev){ref-type="fig"}A). In contrast, neither RFP mRNA nor protein were detectable by *in situ* hybridization or antibody enhancement, respectively, in any other brain area including the hippocampus (Fig [EV1](#embj201798791-fig-0001ev){ref-type="fig"}A and A'), which is likely due to the lower dosage of Tam relative to that optimized for this niche (Imayoshi *et al*, [2008](#embj201798791-bib-0025){ref-type="ref"}; Artegiani *et al*, [2011](#embj201798791-bib-0004){ref-type="ref"}). No RFP protein could be detected either in the olfactory epithelium (Fig [EV1](#embj201798791-fig-0001ev){ref-type="fig"}A) underlying the SVZ‐specific expression of 4D despite the presence of nestin^+^ cells in other regions of the nervous system.

![Characterization of the transgenic model and effect of 4D on the RMS\
AFluorescence image of a sagittal section of a 4D^+^ brain after a 4‐day treatment with doxycycline showing RFP signal confined to the SVZ and RMS (nuclei counterstained with DAPI; blue). Insets show representative images of specific brain regions (as indicated) and the olfactory epithelium.A'Phase contrast picture of the SVZ upon *in situ* hybridization against mRNA for RFP in a 4D^+^ brain treated as in (A) and sacrificed immediately after (left) or 2 days after (right) doxycycline administration.B, CExperimental design (top), fluorescence pictures (left with magnified insets), and quantifications (right) of BrdU incorporation in the RMS (B) or SVZ (C). (B) shows the proportion of BrdU in C (Mash1^+^) and A (DCX^+^) cells in 4D^−^ (white) and 4D^+^ (red; among RFP^+^) mice. (C) shows the proportion of RFP^−^ (black) and RFP^+^ (red) among BrdU^+^ cells of 4D^+^ mice. (A) OB, olfactory bulb; RMS, rostral migratory stream; LV, lateral ventricle; DG, dentate gyrus; OE, olfactory epithelium. (A--C) Tam, tamoxifen; Dox, doxycycline. (B, C) Mean ± SEM; \*\**P *\<* *0.01; unpaired Student\'s *t*‐test; *N* = 3 mice and *n* \> 1,100 cells. Scale bars = 500 (A top, A'), 100 (insets A and A'), 50 (B and C), and 20 (insets B and C) μm.](EMBJ-38-e98791-g003){#embj201798791-fig-0001ev}

Within the SVZ, 4D‐RFP induction occurred to a similar degree in C and A progenitor cells (72.1 ± 4.8 and 68.2 ± 3.2% of all Mash1^+^ and DCX^+^, respectively) and to a lesser extent in activated B1 cells identified as either EGFR^+^Mash1^−^ or nestin^+^S100β^−^ (Codega *et al*, [2014](#embj201798791-bib-0015){ref-type="ref"}; 54.4 ± 6.1 and 55.1 ± 2.8%, respectively; Fig [1](#embj201798791-fig-0001){ref-type="fig"}B). Moreover, RFP mRNA levels were back to undetectable levels 2 days after withdrawing Dox (Fig [EV1](#embj201798791-fig-0001ev){ref-type="fig"}A'), evidencing the efficiency of our on/off expression system and lack of leakiness.

We next investigated the effects of a 4‐day 4D overexpression on proliferation by one pulse of BrdU 12 h before sacrifice (Fig [1](#embj201798791-fig-0001){ref-type="fig"}C). Hereafter, triple homozygous, *nestin* ^CreERT2+/+^/*ROSA26* ^rtTA‐flox+/+^/*tet* ^4D‐RFP−/−^ mice (referred to as 4D^−^) in the same genetic background of 4D^+^ mice and equally treated with Tam and Dox were used as negative controls. First, we quantified the proportion of BrdU^+^ cells among activated B1, C, and A cells in 4D^−^ and 4D^+^ mice. We found that in 4D^+^ mice the vast majority (\> 80%) of RFP^+^ cells was also BrdU^+^ (Fig [1](#embj201798791-fig-0001){ref-type="fig"}C). Consistently, the proportion of BrdU^+^ cells among activated B1 cells had substantially increased relative to 4D^−^ mice (from 6.0 ± 0.3 to 42.9 ± 5.9%, *P *\<* *0.005 and from 28.6 ± 2.1 to 47.7 ± 1.7%, *P *\<* *0.005, among EGFR^+^Mash1^−^ and nestin^+^S100β^−^ cells, respectively). Note that the different fold‐increase by the use of the two marker pairs is likely due to the reported degradation of nestin in S/G2 (Sunabori *et al*, [2008](#embj201798791-bib-0055){ref-type="ref"}; Codega *et al*, [2014](#embj201798791-bib-0015){ref-type="ref"}) during which BrdU is incorporated; Fig [1](#embj201798791-fig-0001){ref-type="fig"}C). A similar increase in the proportion of BrdU^+^ cells was also found among C and A cells in both the SVZ (from 46.9 ± 2.3 to 76.1 ± 5.4%, *P *\<* *0.01 and from 35.8 ± 3.2 to 69.5 ± 6.4%, *P *\<* *0.01, for Mash1^+^ and DCX^+^ cells, respectively; Fig [1](#embj201798791-fig-0001){ref-type="fig"}C) and RMS (from 47.9 ± 2.0 to 78.5 ± 2.1%, *P *\<* *0.01 and from 39.0 ± 10.5 to 65.4 ± 8.8%, *P *=* *0.13, for Mash1^+^ and DCX^+^ cells, respectively; Fig [EV1](#embj201798791-fig-0001ev){ref-type="fig"}B). These data were consistent with the known effect of 4D in shortening G1 (Lange *et al*, [2009](#embj201798791-bib-0029){ref-type="ref"}; Artegiani *et al*, [2011](#embj201798791-bib-0004){ref-type="ref"}; Nonaka‐Kinoshita *et al*, [2013](#embj201798791-bib-0042){ref-type="ref"}) and underlying the observed increase in BrdU incorporation.

Yet, despite the massive increase in BrdU^+^ cells, these results were hard to interpret given that RFP^+^ cells in 4D^+^ mice represented only a fraction (ca. 50%) of all stem and progenitor cells (Fig [1](#embj201798791-fig-0001){ref-type="fig"}B). Hence, comparison of this subpopulation of RFP^+^ cells in 4D^+^ mice with all cells in 4D^−^ mice might have resulted in a bias if RFP expression was to be enriched in fast‐proliferating cells. This was unlikely because BrdU labeling in 4D^+^ mice prior to the beginning of Dox administration, i.e., before a phenotype could be triggered, led to a similar proportion of BrdU^+^ cells among the RFP^−^ and RFP^+^ population (Fig [EV1](#embj201798791-fig-0001ev){ref-type="fig"}C) indicating that 4D‐RFP induction did not bias toward fast‐proliferating cells.

Nevertheless, to directly and incontrovertibly exclude the effects of any potential bias in 4D‐RFP expression, we quantified the absolute number of BrdU^+^ cells in 4D^+^ and 4D^−^ mice regardless of RFP expression. This was also important because the previous increase in the proportion of BrdU^+^ cells (Fig [1](#embj201798791-fig-0001){ref-type="fig"}C) primarily reflected a change in cell cycle parameters, but not necessarily in fate, of neural stem and progenitor cells, which could only be proven by observing an increase in their numbers irrespective of BrdU incorporation.

We found that a 4‐day induction of 4D triggered an increase by 30% in activated B1 cells per tissue volume (from 3.3 ± 0.2 × 10^4^ to 4.4 ± 0.3 × 10^4^, *P *\<* *0.05, and from 51.2 ± 1.4 × 10^4^ to 66.6 ± 4.3 × 10^4^, *P *\<* *0.05, EGFR^+^Mash1^−^ and nestin^+^S100β^−^ cells/mm^3^, respectively) and 15% in C cells (from 43.9 ± 1.6 × 10^4^ to 52.7 ± 1.2 × 10^4^ Mash1^+^ cells/mm^3^, *P *\<* *0.01) throughout the SVZ (Fig [1](#embj201798791-fig-0001){ref-type="fig"}D). This increase in cell numbers in 4D^+^ mice occurred without distinguishing between RFP^−^ and RFP^+^ cells indicating that the real 4D‐triggered effect on cell fate was greater, in principle the double, than the one assessed.

Altogether, the observed increase in the proportion of BrdU incorporation and number of NSC supports the notion (Lange & Calegari, [2010](#embj201798791-bib-0030){ref-type="ref"}; Borrell & Calegari, [2014](#embj201798791-bib-0009){ref-type="ref"}) that 4D overexpression not only induces a faster cell cycle in NSC but also changes their fate by promoting proliferative divisions and expansion of their pool over time.

4D expands NSC without inducing their depletion and increases neurogenesis {#embj201798791-sec-0004}
--------------------------------------------------------------------------

We next addressed the long‐term effect of an acute 4D overexpression. In particular, we investigated whether (i) enhanced NSC proliferation was reversible upon turning off 4D, thus allowing their switch to differentiation; (ii) supernumerary NSC could re‐enter quiescence, which is essential to prevent their long‐term depletion; (iii) the balance between gliogenic vs. neurogenic commitment was maintained without altering NSC multipotency; and finally, (iv) expansion of NSC increased neurogenesis without compensatory effects. To address all these questions, we designed a common experimental paradigm by which 4D was induced for 4 days concomitantly with BrdU administration followed by a 30‐ or 60‐day chase without Dox (Figs [2](#embj201798791-fig-0002){ref-type="fig"}A and [EV2](#embj201798791-fig-0002ev){ref-type="fig"}A).

![Chronic effect of 4D overexpression on NSC and OB neurogenesis\
AExperimental design used to assess the chronic effect of a transient 4D induction with BrdU and EdU given during Dox administration or 1 h before sacrifice, respectively.B--EFrom top to bottom: fluorescence pictures of the SVZ (B--D) or OB (E) and absolute number (B, C, and E) or proportions (C--E) of cells in 4D^−^ (white bars) or 4D^+^ (black or red bars for all or RFP^+^ cells, respectively) mice scored positive for various markers as indicated. Insets in (C) are magnified (right) with arrowheads pointing label‐retaining NSC (white) or astrocytes (empty). Arrowheads in (D) point cell doublets (among RFP^+^ protein‐retaining cells in 4D^+^). (E) GL, glomerular; EPL, external plexiform; MCL, mitral cell and GCL, granule cell layers.Data information: (B--E) Mean ± SEM; \**P *\<* *0.05, \*\**P *\<* *0.01 assessed by unpaired Student\'s *t*‐test (bar graphs) or Fisher\'s exact test (pie graphs); *N* = 3 mice, *n* \> 285 cells for each quantification. Scale bars = 50 μm (B, C, and E) and 20 μm (D and insets in C).](EMBJ-38-e98791-g004){#embj201798791-fig-0002}

![Long‐term effect of 4D overexpression on NSC and OB neurogenesis\
AExperimental paradigm to investigate long‐term effects of 4D expression. Tam, tamoxifen; Dox, doxycycline.B, CFrom left to right: fluorescence pictures of the SVZ (B) or OB (C) and number per mm^3^ (bar graphs) or proportions (pie graphs), of cells in 4D^−^ (left pictures and white bars) or 4D^+^ (right pictures and black bars) mice and scored positive for markers as indicated. Insets in (B) are magnified (right) with arrowheads pointing label‐retaining NSC (white) or astrocytes (empty). (C) GL, glomerular; EPL, external plexiform; MCL, mitral cell; and GCL, granule cell layers. (B, C) Mean ± SEM; \**P *\<* *0.05, \*\**P *\<* *0.01; unpaired Student\'s *t*‐test or Fisher\'s exact test (pie graphs); *N* = 4 mice, *n* \> 210 cells. Scale bars = 50 (B and C) and 20 (caption in B) μm.](EMBJ-38-e98791-g005){#embj201798791-fig-0002ev}

First, at the end of the described treatment, a single pulse of EdU was given 1 h before sacrifice to investigate whether the 4D effect on the cell cycle and proliferation was reversible (Fig [2](#embj201798791-fig-0002){ref-type="fig"}A). No difference was found in the number of EdU^+^ cells (31.4 ± 3.2 × 10^4^ and 33.2 ± 1.7 × 10^4^ EdU^+^ cells/mm^3^ in 4D^−^ and 4D^+^ mice, respectively, *P *=* *0.66), indicating that the 4D effect was fully reversible and proliferation was restored back to physiological levels (Fig [2](#embj201798791-fig-0002){ref-type="fig"}B).

Second, BrdU label retention was used to address entry into quiescence (Doetsch *et al*, [1999](#embj201798791-bib-0017){ref-type="ref"}). NSC that were cycling during Dox administration and retained the label following a 30‐day chase were identified as BrdU^+^Sox2^+^S100β^−^ (Fig [2](#embj201798791-fig-0002){ref-type="fig"}C; white arrowheads) and found to have increased by twofold in 4D^+^ mice relative to control (1.9 ± 0.3 × 10^4^ vs. 3.8 ± 0.3 × 10^4^ cells/mm^3^, *P *\<* *0.01; Fig [2](#embj201798791-fig-0002){ref-type="fig"}C). This twofold increase in long‐term, label‐retaining cells seemingly persisted even after a 60‐day chase despite the overall age‐dependent decrease in the number of quiescent NSC in both cohorts of mice (1.1 ± 0.1 × 10^4^ vs. 1.8 ± 0.3 × 10^4^ BrdU^+^Sox2^+^S100β^−^ cells/mm^3^ in 4D^−^ and 4D^+^, respectively, *P *=* *0.09; Fig [EV2](#embj201798791-fig-0002ev){ref-type="fig"}A and B), suggesting a long‐term effect by our manipulation without NSC depletion.

Intriguingly, in these experiments quiescent NSC also seemed to appear more frequently as doublets in 4D^+^ than in 4D^−^ mice (Fig [2](#embj201798791-fig-0002){ref-type="fig"}D, arrowheads) suggesting that they were the result of an increase in symmetric, relative to asymmetric, proliferative divisions, both of which are known to occur in the mouse SVZ (Calzolari *et al*, [2015](#embj201798791-bib-0013){ref-type="ref"}). To investigate this, we took advantage of the fact that while 4D‐RFP mRNA expression was terminated soon after Dox removal (Fig [EV1](#embj201798791-fig-0001ev){ref-type="fig"}A'), RFP as a protein persisted over 1 month later (Fig [2](#embj201798791-fig-0002){ref-type="fig"}D). Hence, we ranked the proportion of BrdU^+^RFP^+^ cells that appeared as doublets (nuclei within 10‐μm distance) along the SVZ as a proxy for symmetric divisions, revealing a 30% increase in 4D^+^ mice as compared to 4D^−^ (from 51.7 ± 1.7 to 67.5 ± 5.1%, *P *\<* *0.05; Fig [2](#embj201798791-fig-0002){ref-type="fig"}D) and consistent with the notion that symmetric proliferative divisions underlie the expansion of NSC and their increase in number (Fig [1](#embj201798791-fig-0001){ref-type="fig"}D).

Third, regarding lineage commitment and multipotency of 4D‐expanded NSC, we quantified the proportion of BrdU long‐term retaining cells expressing the gliogenic marker S100β and found a similar proportion of mature astrocytes in 4D^−^ and 4D^+^ (43.2 ± 6.5 and 48.0 ± 4.6%, respectively, *P *=* *0.57; Fig [2](#embj201798791-fig-0002){ref-type="fig"}C; pie graphs). Hence, as a result of the increased number of NSC and similar proportion of gliogenic commitment, the number of mature astrocytes was also increased in 4D^+^ mice by twofold (1.5 ± 0.1 × 10^4^ vs. 3.6 ± 0.8 × 10^4^ BrdU^+^S100β^+^ cells/mm^3^ in 4D^−^ vs. 4D^+^, respectively, *P *\<* *0.05; Fig [2](#embj201798791-fig-0002){ref-type="fig"}C; bar graphs). Similar differences were also found after the 60‐day chase (0.9 ± 0.1 × 10^4^ vs. 1.3 ± 0.2 × 10^4^ BrdU^+^S100β^+^ cells/mm^3^ in 4D^−^ vs. 4D^+^, respectively, *P *=* *0.07; Fig [EV2](#embj201798791-fig-0002ev){ref-type="fig"}B).

Finally, we investigated whether the transitorily expanded pool of NSC was capable of undergoing physiological neurogenesis upon silencing of the 4D cassette. Consistent with this, CLARITY treated, whole‐mount immunolabeling of 4D^+^ brains showed widespread distribution of RFP^+^ cells throughout the entire OB ([Movie EV1](#embj201798791-sup-0003){ref-type="supplementary-material"}). Then, we quantified BrdU^+^ neurons in the OB birthdated during 4D overexpression. In adult mice, most of the newly generated neurons migrating to the OB integrate in the granule cell layer as NeuN^+^, GABAergic granule cells (Bagley *et al*, [2007](#embj201798791-bib-0006){ref-type="ref"}; Imayoshi *et al*, [2008](#embj201798791-bib-0025){ref-type="ref"}; Fig [2](#embj201798791-fig-0002){ref-type="fig"}E). Additionally, a smaller proportion of GABAergic, glutamatergic or dopaminergic periglomerular interneurons is added to the glomerular layer that can be classified in three mutually exclusive populations of calretinin^+^ (CalR), calbindin^+^ (CalB), or tyrosine hydroxylase^+^ (TH) cells (Hack *et al*, [2005](#embj201798791-bib-0024){ref-type="ref"}; Parrish‐Aungst *et al*, [2007](#embj201798791-bib-0045){ref-type="ref"}; Brill *et al*, [2009](#embj201798791-bib-0012){ref-type="ref"}). We observed an evident increase in BrdU^+^ neurons in 4D^+^ mice (Fig [2](#embj201798791-fig-0002){ref-type="fig"}E) that contributed to the granule cell and glomerular layers in proportions similar to that observed in 4D^−^ mice (82.6 ± 1.3 and 17.4 ± 1.3% vs. 82.8 ± 2.2 and 17.2 ± 2.2%, for granule cell and glomerular layers, in 4D^+^ and 4D^−^ mice, respectively, *P *=* *1.0; Fig [2](#embj201798791-fig-0002){ref-type="fig"}E; pie graphs). Regarding absolute numbers, 30 days after 4D overexpression we observed a similar increase in all neuronal types that reached our threshold of statistical significance for both NeuN^+^ granule cells (from 4.42 ± 0.46 × 10^4^ to 6.05 ± 0.36 × 10^4^ cells/mm^3^, *P *\<* *0.05) and TH^+^ periglomerular cells (from 0.23 ± 0.03 × 10^4^ to 0.44 ± 0.07 × 10^4^ cells/mm^3^, *P *\<* *0.05; Fig [2](#embj201798791-fig-0002){ref-type="fig"}E). Similar differences were found after the 60‐day chase, time at which also the increase in CalB^+^ cells reached statistical significance (Fig [EV2](#embj201798791-fig-0002ev){ref-type="fig"}C).

Together, these data outline the effects of 4D on NSC resulting in their long‐term expansion and increased neurogenesis without affecting their multipotency or compensatory effects due to depletion and/or neuronal death.

4D expression in NSC does not alter the morphology or activity of supernumerary neurons {#embj201798791-sec-0005}
---------------------------------------------------------------------------------------

We next assessed whether the integration and activity of supernumerary neurons was altered by the nature of our manipulation in progenitor cells. To this aim, we focussed on granule cells since they represent the most abundant type of adult born neurons playing key roles in olfactory discrimination (Abraham *et al*, [2010](#embj201798791-bib-0002){ref-type="ref"}; Alonso *et al*, [2012](#embj201798791-bib-0003){ref-type="ref"}; Gschwend *et al*, [2015](#embj201798791-bib-0023){ref-type="ref"}; Nunes & Kuner, [2015](#embj201798791-bib-0043){ref-type="ref"}). NSC expansion was induced for 4 days and granule cells in the OB analyzed 30 days later (Fig [3](#embj201798791-fig-0003){ref-type="fig"}A), time at which adult born neurons are known to be morphologically mature and integrated (Petreanu & Alvarez‐Buylla, [2002](#embj201798791-bib-0046){ref-type="ref"}). Here, in contrast to our previous quantifications of cell numbers alone (Figs [1](#embj201798791-fig-0001){ref-type="fig"} and [2](#embj201798791-fig-0002){ref-type="fig"}), we needed a system that would allow us to identify supernumerary RFP^+^ neurons in 4D^+^ mice and compare them with physiologically generated, RFP^−^ newborn neurons of an equivalent age in 4D^−^ or even within 4D^+^ mice. To mark such age‐matched cohort of newborn neurons in 4D^−^ and 4D^+^ mice, we then crossed the homozygous 4D^−^ and 4D^+^ lines with *RCE* ^*GFP‐flox*+/+^ mice (Miyoshi *et al*, [2010](#embj201798791-bib-0037){ref-type="ref"}), thus, labeling *nestin*CreERt2+ NSC upon Tam administration by GFP, irrespective from the presence or absence of RFP. We then compared superficial granule neurons derived from 4D^+^ NSC (RFP^+^GFP^+^) with physiologically generated neurons of the equivalent age but derived from 4D^−^ NSC (RFP^−^GFP^+^).

![Integration and electrophysiological properties of 4D‐derived granule cells\
AExperimental design to assess the integration of 4D‐derived neurons.BFluorescence pictures (left) of immunolabeled GFP^+^RFP^−^ (4D^−^) and GFP^+^RFP^+^ (4D^+^) apical dendrites of superficial granule neurons and quantifications (middle and right) of spine density and total dendritic length (box and whiskers) and 3D‐Sholl (line graph profile) of apical dendrites starting from the soma (drawings) as the mean number of intersections at 10‐μm intervals.C3D reconstruction of multi‐channel confocal stacks acquired from a RFP^+^ apical dendrite of a granule cell showing co‐localization with the pre‐ and post‐synaptic markers VIAAT (granule neuron) and gephyrin (mitral cell), respectively (magnification shown in insets).DAnti‐RFP immunogold labeling of a cell in the superficial granule cell layer of a 4D^+^ mouse. Inset shows a representative RFP^+^ synapse (out of \> 10 analyzed from 4D^+^ mice).E--GCurrent clamp recordings showing examples of spontaneous barrages of synaptic potentials (E), and repetitive spiking in response to depolarizing current steps (F, G) of 4D^−^ (top) and 4D^+^ (bottom) mice. Inset in E (4D^+^ cell) is magnified (bottom). Note in (G) that the lag preventing spike initiation is longer at lower currents (green) and shorter at higher (black), suggesting the presence of an A‐type K current typical of granule cells in 4D^−^ vs. 4D^+^.HBox and whiskers plots representing electrophysiological properties of neurons derived from 4D^−^ and 4D^+^ NSC (black and red, respectively) including from left to right: spike number, resting membrane potential (Vrest), input resistance (Rin), and lag to spiking of the recorded superficial granule cells (see Fig [EV3](#embj201798791-fig-0003ev){ref-type="fig"} for additional parameters).Data information: Data are presented as mean ± SEM in the line graph in panel (B). No significant difference was found by unpaired Student\'s *t*‐test (throughout) or repeated measures two‐way ANOVA (line graph in B). Boxplots in (B and H) show the median (horizontal line), and mean (+) and whiskers indicate the lowest and highest values within 1.5 interquartile range. Outliers were identified by Tukey\'s test. (B) *N* = 3 mice, *n* \> 8 neurons per genotype; (E--H) *N* \> 5 mice, *n* = 12 4D^−^ and 10 4D^+^ neurons. Scale bars = 5 μm (B and C), 1 μm (D and insets in C), and 0.5 μm (inset in D).](EMBJ-38-e98791-g006){#embj201798791-fig-0003}

Morphometric and 3D‐Sholl analyses revealed that spine density (0.36 ± 0.02 vs. 0.33 ± 0.03 spines/μm, 4D^−^ and 4D^+^, respectively, *P *=* *0.44), total dendritic length (0.78 ± 0.6 and 0.66 ± 0.8 mm, *P *=* *0.26), and arborization (intersections as a function of distance from the soma *F* ~(1,28)~ = 0.61, *P *=* *0.44) were comparable in granule cells derived from 4D^−^ and 4D^+^ NSC (Fig [3](#embj201798791-fig-0003){ref-type="fig"}B) and fitting well with previous reports (Abraham *et al*, [2010](#embj201798791-bib-0002){ref-type="ref"}; Scotto‐Lomassese *et al*, [2011](#embj201798791-bib-0052){ref-type="ref"}; Breton‐Provencher *et al*, [2016](#embj201798791-bib-0011){ref-type="ref"}). 4D‐derived granule neurons expressed the presynaptic vesicular GABA transporter VIAAT that co‐localized with the post‐synaptic marker gephyrin (Nunes & Kuner, [2015](#embj201798791-bib-0043){ref-type="ref"}; Fig [3](#embj201798791-fig-0003){ref-type="fig"}C). Moreover, characteristic synaptic clefts and vesicles were observed in 4D‐derived neurons at the ultrastructural level by electron microscopy upon RFP immunogold labeling (Fig [3](#embj201798791-fig-0003){ref-type="fig"}D), thus evidencing the presence of mature synapses.

To further confirm the functional integration of 4D‐derived neurons, we next assessed their electrophysiological properties. Patch‐clamp recordings in the OB were performed on slices from 4D^−^ and 4D^+^ mice comparing newborn granule neurons identified by GFP and/or RFP expression as described above. This showed that both cohorts of neurons received spontaneous barrages of synaptic input of similar frequency and amplitude (values for 4D^−^ vs. 4D^+^, respectively: 2.9 ± 0.8 vs. 3.6 ± 0.8 Hz, *P *=* *0.52; 2.6 ± 0.5 vs. 2.7 ± 0.7 mV, *P *=* *0.87; Figs [3](#embj201798791-fig-0003){ref-type="fig"}E and [EV3](#embj201798791-fig-0003ev){ref-type="fig"}B). Properties of action potentials in response to depolarizing current steps were also similar as well as input resistance and resting membrane potential (spike number: 12.5 ± 0.9 vs. 13.7 ± 2.8 spikes/500 ms, *P *=* *0.71; spike width: 1.7 ± 0.1 vs. 1.4 ± 0.1 ms, *P *=* *0.12; spike amplitude: 66.7 ± 3.5 vs. 72.3 ± 4.8 mV, *P *=* *0.35 and after hyperpolarization: 38.1 ± 3.9 vs. 43.1 ± 2.3, *P *=* *0.33; R~in~: 892.7 ± 86.6 vs. 956.8 ± 103.7 MΩ, *P *=* *0.64 and V~rest~: −66.0 ± 3.4 vs. −60.7 ± 4.2 mV, *P *=* *0.33; Figs [3](#embj201798791-fig-0003){ref-type="fig"}F and H, and [EV3](#embj201798791-fig-0003ev){ref-type="fig"}B). We also compared several other parameters including capacitance, voltage threshold for spike initiation, and rheobase, which in all cases yielded expected, and virtually identical, values between age‐matched cohorts of physiologically generated and 4D‐derived neurons (Fig [EV3](#embj201798791-fig-0003ev){ref-type="fig"}B). Finally, both cohorts of neurons displayed the characteristic lag in the initiation of the first action potential in response to prolonged current injection (78.5 ± 12.2 vs. 79.5 ± 12.3 ms, *P *=* *0.95; Fig [3](#embj201798791-fig-0003){ref-type="fig"}G and H) consistent with the presence of A‐type K^+^ currents typical of granule cells (Schoppa & Westbrook, [1999](#embj201798791-bib-1000){ref-type="ref"}).

![Electrophysiological parameters\
Experimental design to assess the integration of 4D‐derived neurons.Box and whiskers plots extending the electrophysiological analyses of GFP^+^/RFP^−^ (black) and GFP^+^/RFP^+^ (red) patched superficial granule neurons shown in Fig [3](#embj201798791-fig-0003){ref-type="fig"}E--H. From left to right: frequency and amplitude of excitatory post‐synaptic potential (EPSP), spike width and amplitude (top) and after hyperpolarization (AHP), membrane capacitance (Cm), voltage threshold (Vth), and rheobase (bottom). Significance was calculated by unpaired Student\'s *t*‐test and outliers identified by Tukey\'s test; *N* \> 5 mice, *n* \> 10--12 neurons. Scale bars = 10 μm.](EMBJ-38-e98791-g007){#embj201798791-fig-0003ev}

In summary, both morphometric and electrophysiological analyses (Figs [3](#embj201798791-fig-0003){ref-type="fig"} and [EV3](#embj201798791-fig-0003ev){ref-type="fig"}), together with our previous assessment of molecular markers (Fig [2](#embj201798791-fig-0002){ref-type="fig"}), confirmed that the maturation, integration, and activity of 4D‐derived granule cells were in all aspects similar to that of physiologically generated neurons. This contrasts the differences observed in endogenous vs. graft‐derived interneurons following transplantation of neural precursors (Larimer *et al*, [2017](#embj201798791-bib-0031){ref-type="ref"}) suggesting that supernumerary neurons by our 4D manipulation in NSC not only are similar in cell‐intrinsic properties but also have no competitive disadvantage compared to endogenous neurons. This in turn distinguishes our approach from previous studies assessing the role of neurogenesis in olfaction upon manipulations changing the intrinsic properties of the neurons themselves and/or their niche.

Increased neurogenesis improves discrimination accuracy of highly similar odors {#embj201798791-sec-0006}
-------------------------------------------------------------------------------

To investigate the potential contribution of the supernumerary neurons on olfaction, we treated mice as previously described (Fig [3](#embj201798791-fig-0003){ref-type="fig"}A) followed by a go/no‐go odor discrimination task (Fig [4](#embj201798791-fig-0004){ref-type="fig"}A). In particular, mice were exposed to either of two odorants and learned to discriminate between the unrewarded and rewarded stimulus after which mice are expected to remove their head from the sampling port or keep it in and lick for water, respectively (Abraham *et al*, [2010](#embj201798791-bib-0002){ref-type="ref"}; Nunes & Kuner, [2015](#embj201798791-bib-0043){ref-type="ref"}; Fig [4](#embj201798791-fig-0004){ref-type="fig"}B). This allowed the assessment of learning performance calculated as the percentage of correct responses over testing as well as the discrimination time (DT) defined as the time needed to decide how to respond to the odorants at maximal accuracy (referred to as criterion; see [Materials and Methods](#embj201798791-sec-0008){ref-type="sec"} and [Appendix](#embj201798791-sup-0001){ref-type="supplementary-material"}).

![Effect of increased neurogenesis on olfaction\
Experimental design to test effects on olfaction.Scheme of the go/no‐go odor discrimination task. Mice introduce their head in the sampling port breaking the infrared beam (IR). A correct response is scored when mice retract their head in the presence of an unrewarded odor or, alternatively, wait and lick for a rewarded one. See additional information in [Appendix](#embj201798791-sup-0001){ref-type="supplementary-material"}.Line graph indicating the proportion of correct responses (performance) for bins of 100 trials each during testing with binary mixtures of concentrated octanols. Discontinuous line indicates the similar 95% plateau performance of 4D^−^ (black) and 4D^+^ (red) mice.Box‐and‐whisker plots of performance (left) and lick frequency (right) during a probe of 200 trials with 1:10 diluted octanols after testing as in (C).Data information: (C) Mean ± SEM with significance assessed by repeated measures two‐way ANOVA. (D) Unpaired Student\'s *t*‐test \**P *\< 0.05 and \*\**P *\<* *0.001. Boxplots show the median (horizontal line) and mean (+). Whiskers indicate the lowest and highest values within 1.5 interquartile range. Cohorts of *N* = 21/17 (C) or 15/10 (D) 4D^−^/4D^+^ mice were used.](EMBJ-38-e98791-g008){#embj201798791-fig-0004}

Mice were serially exposed to discrimination tasks of increasing difficulty. To start with, amyl acetate (AA) and ethyl butyrate (EB) were used as pure odorants and, sequentially, as binary mixtures at 40/60% vs. 60/40%. In either case, a similar learning performance (group *F* ~1,36~ = 1.09 and 1.96, *P *=* *0.30 and 0.17 for pure odors and binary mixtures, respectively) was found in 4D^−^ and 4D^+^ mice (Fig [EV4](#embj201798791-fig-0004ev){ref-type="fig"}B). We then used two enantiomers of the same odorant, (−) or (+)‐octanol, as a more difficult task but again no difference was found neither using pure odors (group *F* ~1,35~ = 0.001, *P *=* *0.97) nor their binary mixtures (group *F* ~1,33~ = 0.24, *P *=* *0.63; Figs [EV4](#embj201798791-fig-0004ev){ref-type="fig"}B and [4](#embj201798791-fig-0004){ref-type="fig"}C). Furthermore, no difference was observed in DTs of 4D^−^ and 4D^+^ mice in any of these discrimination tasks (Fig [EV4](#embj201798791-fig-0004ev){ref-type="fig"}C).

![Performance and DTs at different discrimination tasks\
Experimental design used to test effects on olfaction. Tam, tamoxifen; Dox, doxycycline.Line graphs indicating the proportion of correct responses (performance) for bins of 100 trials during testing with (from left to right): pure and binary mixture of AA vs. EB and pure and 1:10 diluted binary mixture of (−) vs. (+)‐octanols. Discontinuous line indicates the similar 95% plateau performance of 4D^−^ (black) and 4D^+^ (red) mice.Box and whiskers plots representing the DTs calculated at 95% performance. Note that DTs are slower using the automated olfactometer compared with the previously used olfactometers owing to differences in odor port design (Abraham *et al*, [2010](#embj201798791-bib-0002){ref-type="ref"}). (C) AA, amyl acetate; EB, ethyl butyrate; oct, octanol.Data information: Mean ± SEM with significance tested by repeated measures two‐way ANOVA (B) or unpaired Student\'s *t*‐test with outliers identified by Tukey\'s test (C). Cohorts of *N* = 21/17 or 15/10 for 1:10 dilution (B; right) 4D^−^/4D^+^ mice were used.](EMBJ-38-e98791-g009){#embj201798791-fig-0004ev}

However, in all these tasks mice typically reached the criterion (\> 95% performance) within the first 200--500 trials and maintained this high performance throughout the testing. This raised the possibility that the stimuli were too easy to discriminate and that the task could be efficiently performed independently from any potential gains that an increase in the number of newly integrated granule cells could provide. In other words, the stimuli tested so far might not have pushed the olfactory system into the critical range of performance within which differences in the number of newborn granule cells may become physiologically relevant.

To address this, we subjected the mice already tested on the binary mixture of enantiomers (Fig [4](#embj201798791-fig-0004){ref-type="fig"}C) to the same task but this time with odorants diluted 1:10 as a probe trial after that a similar maximal performance was reached in the previous task. Notably, this mixture and dilution of octanols was intentionally chosen as one of the most challenging olfactory tasks that mice can perform but still at a dilution range above the detection threshold (preprint: Abraham *et al*, [2018](#embj201798791-bib-0500){ref-type="ref"}) to specifically assess discrimination performance rather than detectability. As an evidence of the difficulty of this task, both groups of mice for the first time failed to reach the previous 95% performance and remained at a lower efficiency of about 70%. In this probe test, we found that 4D^+^ mice showed a significantly better discrimination accuracy that increased their performance relative to 4D^−^ controls from 65.8 ± 2.9 to 72.1 ± 3.2% (*P *\<* *0.05; Fig [4](#embj201798791-fig-0004){ref-type="fig"}D). This increased performance of 4D^+^ mice was maintained throughout the testing with no obvious effect over time (Fig [EV4](#embj201798791-fig-0004ev){ref-type="fig"}B; right). Moreover, when assessing the proportion of trials in which mice licked to receive water irrespective of the odorant being presented, we found that control mice licked more often than 4D^+^ (65.3 ± 3.3 and 49.0 ± 4.8, *P *\<* *0.01; Fig [4](#embj201798791-fig-0004){ref-type="fig"}D). In essence, this suggested that during the diluted octanol trials the lower performance of control mice induced them to lick more often to compensate for the average decrease in total water obtained relative to 4D^+^.

Altogether, these data highlight the effect of an additional supply of newborn neurons in improving olfactory accuracy and increasing discrimination performance specifically in an extremely challenging task.

Discussion {#embj201798791-sec-0007}
==========

Previous studies reported that an expansion of NSC in the adult hippocampus was sufficient to improve cognitive performance (Cao *et al*, [2004](#embj201798791-bib-0014){ref-type="ref"}; Sahay *et al*, [2011](#embj201798791-bib-0048){ref-type="ref"}; Stone *et al*, [2011](#embj201798791-bib-0054){ref-type="ref"}). However, experiments establishing a link between NSC expansion and brain function in the second and major adult neurogenic niche of the SVZ are lacking.

Here, we reported a system to expand long‐term multipotent NSC of the adult SVZ by an increase in symmetric proliferative divisions and without inducing their depletion. Moreover, the transient nature of our manipulation allowed us to switch this expanded pool of NSC back to neurogenesis resulting in an increase in newborn neurons integrating in the brain circuitry and preserving a seemingly normal expression of molecular markers, morphology and electrophysiological properties. As a result, this led to an improvement in odor discrimination accuracy specifically when mice were challenged by highly similar odorants. Several observations of our study are worth discussing.

First, validating the notion that a short cell cycle acts as a determinant of somatic stem cell fate (Lange & Calegari, [2010](#embj201798791-bib-0030){ref-type="ref"}; Borrell & Calegari, [2014](#embj201798791-bib-0009){ref-type="ref"}), 4D was originally shown to promote the expansion of NSC in the developing and adult brain (Lange *et al*, [2009](#embj201798791-bib-0029){ref-type="ref"}; Artegiani *et al*, [2011](#embj201798791-bib-0004){ref-type="ref"}; Nonaka‐Kinoshita *et al*, [2013](#embj201798791-bib-0042){ref-type="ref"}) and more recently also of human hematopoietic stem cells upon bone marrow transplantation (Mende *et al*, [2015](#embj201798791-bib-0035){ref-type="ref"}), pancreatic β‐cell precursors in models of diabetes (Azzarelli *et al*, [2017](#embj201798791-bib-0005){ref-type="ref"}; Krentz *et al*, [2017](#embj201798791-bib-0027){ref-type="ref"}), and cardiomyocytes during heart regeneration (Mohamed *et al*, [2018](#embj201798791-bib-0039){ref-type="ref"}). Thus, on a purely technical ground, our *ROSA26* ^rtTA‐flox+/+^/*tet* ^4D‐RFP+/+^ mouse line, after crossing with any appropriate Cre line of choice, offers the unique possibility to temporarily control the expansion of, in principle, any somatic stem cell as a powerful new approach for basic research and experimental models of regenerative therapy.

Second, many studies investigated the role of adult SVZ neurogenesis by depleting NSC and/or altering the properties of the neurons themselves at the level of their migration, survival, integration, and/or electrophysiological activity (Mouret *et al*, [2009](#embj201798791-bib-0040){ref-type="ref"}; Abraham *et al*, [2010](#embj201798791-bib-0002){ref-type="ref"}; Alonso *et al*, [2012](#embj201798791-bib-0003){ref-type="ref"}; Gschwend *et al*, [2015](#embj201798791-bib-0023){ref-type="ref"}; Nunes & Kuner, [2015](#embj201798791-bib-0043){ref-type="ref"}; Wang *et al*, [2015](#embj201798791-bib-0056){ref-type="ref"}). While this led to several conflicting results and a controversy in the field, our approach was fundamentally different with the transient nature of our manipulation specifically within NSC ensuring that the supernumerary neurons were not affected by ectopic gene expression, hence, preserving their intrinsic physiological properties and true function. This was particularly the case by using 4D. In fact, not only were the two functional transgenes Cdk4 and cyclinD1 transitorily expressed solely in NSC but also cyclinD1 is known to be degraded before entry in S phase, hence, preventing the inheritance of any residual protein by the neuronal progeny. As a result, the cyclinD1‐dependent activity of Cdk4 ensures that also this second transgene would become biologically inactive in newborn neurons. Consistently, no detectable difference was found in 4D‐derived, supernumerary neurons neither at the level of their migration, survival, integration, maturation, and including the expression of several molecular markers, their morphological properties and electrophysiological activity.

In these settings, third, an increase in newborn neurons induced no visible effect in olfaction in easy discrimination tasks with both control and 4D^+^ mice reaching a similar maximum performance of nearly 100%. Yet, a significant improvement was observed when the task was made sufficiently difficult to reduce performances to only about 70%. Notably, such improvement appeared despite the fact that several limitations contributed to a substantial underestimation of the phenotypes assessed. Among them, in this study 4D was activated only within a subpopulation of about 50% of NSC implying that the effects could have been greater, in principle the double, than the ones assessed. More importantly, when examining the number of newly integrated granule cells, we found in 4D^+^ mice an increase by approximately 40% relative to controls. Yet, when extrapolating the relative contribution of this subpopulation of newborn neurons as a proportion of the total number of all mature granule cells in the OB (ca. 15%; Ninkovic *et al*, [2007](#embj201798791-bib-0041){ref-type="ref"}), this 4D‐induced increase represented only a few percent (ca. 5%) of the total. This has the important implication that even a relatively small addition of newborn neurons was sufficient to trigger a significant effect on brain function provided that the task was made sufficiently difficult to make such a small increase functionally relevant. This in turn raises new questions for future studies with regard to further potential gains in brain function(s) that were not observed, or simply not addressed, in our current study should our manipulation be optimized to increase neurons beyond what currently achieved. These may include new potential gains in learning, DT and/or switching the physiological threshold of detection or discrimination in new tasks with exceptionally diluted odorants.

Finally, fourth, NSC of embryonic origin populate specific areas the postnatal brain (Fuentealba *et al*, [2015](#embj201798791-bib-0019){ref-type="ref"}; Furutachi *et al*, [2015](#embj201798791-bib-0020){ref-type="ref"}) and generate neurons that in humans integrate in the neonatal frontal lobes (Sanai *et al*, [2011](#embj201798791-bib-0051){ref-type="ref"}; Paredes *et al*, [2016](#embj201798791-bib-0044){ref-type="ref"}) and adult striatum (Ernst *et al*, [2014](#embj201798791-bib-0018){ref-type="ref"}). As a result, a number of sensorimotor, cognitive, and neurodegenerative diseases, among others epilepsy, autism, and Huntington\'s, are thought to involve postnatal neurogenesis (Ernst *et al*, [2014](#embj201798791-bib-0018){ref-type="ref"}; Paredes *et al*, [2016](#embj201798791-bib-0044){ref-type="ref"}). Our finding that expansion of NSC and an overall relatively minor increase in the total number of neurons improved discrimination performance in physiological conditions provides a proof‐of‐principle and potential approach toward exploring the use of endogenous NSC to promote recovery of brain function in aging or disease.

Materials and Methods {#embj201798791-sec-0008}
=====================

Animals and treatments {#embj201798791-sec-0009}
----------------------

Triple transgenic 4D^−^ and 4D^+^ mice were generated starting from the individual heterozygous lines previously described (Nonaka‐Kinoshita *et al*, [2013](#embj201798791-bib-0042){ref-type="ref"}). After genetic background homogenization for \> 5 generations, triple homozygous 4D^−^ and 4D^+^ were selected as founders that were eventually crossed with *RCE* ^*GFP‐flox*+/+^ mice (Miyoshi *et al*, [2010](#embj201798791-bib-0037){ref-type="ref"}) for morphometrical and electrophysiological measurements (see [Appendix](#embj201798791-sup-0001){ref-type="supplementary-material"} for additional information about the strategy used to obtain these lines). Tamoxifen (Sigma) was administered at 250, 9‐tert‐butyl doxycycline (Echelon Biosciences) at 50, BrdU (Sigma) at 50, and EdU (Sigma) at 5 mg/kg body weight (see [Appendix](#embj201798791-sup-0001){ref-type="supplementary-material"}). Mice were anesthetized with pentobarbital and perfused transcardially with PBS followed by 4% PFA fixation. Animal procedures were approved by local authorities (DD24‐9168.11‐1/2011‐11, TVV13/2016, and HD35‐9185.81/G‐61/15).

Immunohistochemistry and *in situ* hybridization {#embj201798791-sec-0010}
------------------------------------------------

Perfused brains were post‐fixed overnight in 4% PFA at 4°C. For histology, 40‐μm‐thick vibratome sections were stored at −20°C in cryoprotectant solution (25% ethylene glycol and 25% glycerol in PBS). Immunohistochemistry was performed as described (Artegiani *et al*, [2011](#embj201798791-bib-0004){ref-type="ref"}). Briefly, blocking and permeabilization were performed in 10% donkey serum, 0.3% Triton X‐100 in PBS for 1 h at RT, and antibodies (Table [1](#embj201798791-tbl-0001){ref-type="table"}) diluted in 3% donkey serum, 0.3% Triton X‐100 in PBS and incubated overnight at 4°C. For BrdU detection, sections were incubated with HCl 2 M for 25 min at 37°C. Eventually, click reaction was performed for EdU detection (Life Technologies). DAPI was used to visualize nuclei. For whole‐mount immunostaining, a modified version of the iDISCO method was used (Renier *et al*, [2014](#embj201798791-bib-0047){ref-type="ref"}; see [Appendix](#embj201798791-sup-0001){ref-type="supplementary-material"}). RFP *in situ* hybridization was performed as described (Nonaka‐Kinoshita *et al*, [2013](#embj201798791-bib-0042){ref-type="ref"}; see [Appendix](#embj201798791-sup-0001){ref-type="supplementary-material"}).

###### 

List of antibodies

  Primary antibodies                                        
  -------------------- --------- -------------------------- -------------
  BrdU                 1:250     Abcam                      ab6326
  CalB                 1:250     Swant                      300
  CalR                 1:250     Swant                      CR 7697
  DCX                  1:100     Santa Cruz Biotechnology   Sc‐8066
  Digoxigenin          1:5,000   Roche                      11093274910
  EGFR                 1:250     Novus Biologicals          nb110‐56945
  Gephyrin             1:300     Synaptic Systems           147 021
  GFP                  1:400     Rockland                   600‐101‐215
  Mash1                1:100     BD Biosciences             556604
  NeuN                 1:250     Millipore                  MAB377
  RFP                  1:2,000   Rockland                   200‐301‐379
  S100β                1:1,000   Abcam                      ab14688
  TH                   1:250     Millipore                  MAB5280
  VIAAT                1:400     Synaptic Systems           131 004

  Secondary antibodies                                                        
  --------------------------- --------- ------------------------------------- ----------
  Alexa Fluor^®^ AffiniPure   1:1,000   Jackson ImmunoResearch Laboratories   
  F(ab')2 GAR Ultra Small     1:30      Aurion                                800--166

From left to right: antigen recognized, dilution used, provider and catalog number of primary (top) and secondary (bottom) antibodies used.

John Wiley & Sons, Ltd

Electron microscopy {#embj201798791-sec-0011}
-------------------

Immunogold labeling was performed as described (Kurth *et al*, [2010](#embj201798791-bib-0028){ref-type="ref"}; see [Appendix](#embj201798791-sup-0001){ref-type="supplementary-material"} and Table [1](#embj201798791-tbl-0001){ref-type="table"}), and samples analyzed on a Morgagni D268 (FEI) or a JEM1400 Plus (JEOL) at 80 kV acceleration voltage.

Image acquisition and cell quantification {#embj201798791-sec-0012}
-----------------------------------------

Immunohistochemistry, *in situ* hybridization, and clarity images were acquired with an automated Zeiss ApoTome, confocal microscope (LSM 780, Carl Zeiss) and Ultramicroscope (LaVision BioTec, Germany), respectively (see [Appendix](#embj201798791-sup-0001){ref-type="supplementary-material"}). For cell quantification, stereological analysis was performed using 1 every six sections from the SVZ and RMS or 1 every three from the OB. For Sholl analyses, z‐stacks separated by 1 μm were 3D reconstructed and dendrites traced using the Fiji plug‐in Simple Neurite Tracer and radii of 10 μm.

Electrophysiology {#embj201798791-sec-0013}
-----------------

300‐μm‐thick vibratome OB slices were used for patch‐clamp whole‐cell recordings using an Axopatch 200B, pClamp10 (Molecular Devices) for generating current steps and Clampfit for data analysis (see [Appendix](#embj201798791-sup-0001){ref-type="supplementary-material"} for a detailed description of electrophysiological measurements).

Olfactometry {#embj201798791-sec-0014}
------------

Behavioral tests were performed by an experimenter blind to the manipulation using a go/no‐go operant conditioning scheme (Abraham *et al*, [2004](#embj201798791-bib-0001){ref-type="ref"}) in a fully automated, custom‐made olfactometer in which non‐olfactory cues were previously assessed and excluded ([Appendix](#embj201798791-sup-0001){ref-type="supplementary-material"}). Eight‐week‐old males were individually marked by a transponder and several parameters assessed during testing, including body weight, licking frequency, circadian rhythms, and others and in which no differences appeared during the course of the tests and/or 4D^−^ vs. 4D^+^ mice ([Appendix](#embj201798791-sup-0001){ref-type="supplementary-material"}). Odors (Table [2](#embj201798791-tbl-0002){ref-type="table"}) were dissolved in mineral oil at a final concentration of 1%. Under these conditions, trained mice retracted their heads from the sampling port when unrewarded odorants were presented or, alternatively, kept their heads inside when facing the rewarded odorant until presentation was completed (2 s) and starting to lick to receive water. Performance was calculated as the percentage of correct responses (go/no‐go and lick) in bins of 100 trials (200 for the probe test). Only mice completing at least 1,000 trials were considered for analysis. Correct trials upon reaching criterion (95% performance) were used to calculate the DT (see [Appendix](#embj201798791-sup-0001){ref-type="supplementary-material"}; Abraham *et al*, [2010](#embj201798791-bib-0002){ref-type="ref"}).

###### 

List of odorants

  Odorants                      
  --------------------- ------- ----------
  Cineole (Cin)         Sigma   \#27395
  Eugenol (Eu)          Fluka   \#46100
  Amyl acetate (AA)     Sigma   \#109584
  Ethyl butyrate (EB)   Sigma   \#E15701
  (+)‐Octanol (+)‐Oct   Fluka   \#74863
  (−)‐Octanol (−)‐Oct   Fluka   \#74865

From left to right: odorant name, provider and catalog number of odorants used.

John Wiley & Sons, Ltd

Statistical analyses {#embj201798791-sec-0015}
--------------------

Data were reported as mean ± SEM. Significance was calculated by two‐tailed, unpaired Student\'s *t*‐test assuming unequal variance throughout except for the use of Fisher\'s exact test for comparing parts of the whole (Figs [2](#embj201798791-fig-0002){ref-type="fig"} and [EV2](#embj201798791-fig-0002ev){ref-type="fig"}) and repeated measures, two‐way ANOVA for Sholl analyses (Fig [3](#embj201798791-fig-0003){ref-type="fig"}) and performance in olfaction (Figs [4](#embj201798791-fig-0004){ref-type="fig"} and [EV4](#embj201798791-fig-0004ev){ref-type="fig"}). Morphometric analysis, electrophysiology, discrimination performance, and licking frequency during the probe test and DTs were represented as whiskers box plots with outliers identified by Tukey\'s test (Figs [3](#embj201798791-fig-0003){ref-type="fig"}, [4](#embj201798791-fig-0004){ref-type="fig"}, [EV3](#embj201798791-fig-0003ev){ref-type="fig"}, and [EV4](#embj201798791-fig-0004ev){ref-type="fig"}). Number of biological replicates, either animals (*N*) and/or cells (*n*), used for quantifications of each experiment were indicated in the respective figure legends.
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